Launch week offerEnds in00h00m00s

annual Promonthly Pro

David Marti-Aguado

Has grant

Juan Rodés Award

INCLIVA Health Research Institute

Spain

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Spain

Recent Grants

Grant: Open

IMAGING MASLD: estudio longitudinal de progresión de la esteatosis hepática metabólica por imágenes de Resonancia Magnética y predicción de eventos clínicos extrahepáticos (PI25/01762)

Open Date: 2026-01-01

Close Date: 2029-01-01

Grant: Close

BioPEth: Desarrollo de un biosensor para cuantificar el consumo de alcohol en gota seca de sujetos en riesgo de enfermedad hepática.

Open Date: 2024-10-01

Close Date: 2026-05-01

Grant: Close

CARDIOHEP: Correlaciones fisiopatológicas entre la enfermedad hepática metabólica y la enfermedad cardiovascular: búsqueda de nuevos biomarcadores

Open Date: 2024-04-01

Close Date: 2025-04-01

Grant: Close

Deep Liver Biopsy: moving towards prognosis and monitoring MASLD

Open Date: 2024-02-01

Close Date: 2026-02-01

Grant: Close

Estudio prospectivo en pacientes con diabetes mellitus tipo 2 para diagnosticar/excluir fibrosis hepática significativa, su posible modificación tras aplicación de medidas dietéticas/farmacológicas y la incidencia de aparición de eventos cardiovasculares durante dos años de seguimiento

Open Date: 2023-12-01

Close Date: 2024-12-01

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Collaborators (28)

Vanesa Bernal-Monterde

SPAIN

David Marti-Aguado

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (20)

Assessing Europe's policy readiness to confront the MASLD/MASH public health threat.

Conceptual framework and expert guidance on intrapancreatic fat deposition: the Melbourne consensus

Risk Stratification to Optimize Colorectal Cancer Screening: Development and Validation of a Decision‐Tree Model for Colonoscopy Prioritization

Development of a machine learning model to identify individuals with VCTE-derived at-risk MASH in a Spanish Mediterranean region

Global multicenter validation of noninvasive fibrosis assessment pathways in MetALD and ALD.

Global trends in national alcohol control policies between 2010 and 2019

1263 PERFORMANCE AND RISK OF FALSE NEGATIVES IN CLINICAL PATHWAYS TO IDENTIFY ADVANCED FIBROSIS IN METALD AND ALD

Mo2019 IMPACT OF DYNAMIC CHANGES IN VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY ON LIVER-RELATED EVENTS IN STEATOTIC LIVER DISEASE

SAT-003-YI Risk of advanced fibrosis and cancer in a population-based colorectal cancer screening program: implications for EASL casefinding strategies

SAT-538 Quantification of hepatic steatosis: a prospective multicenter head-to-head comparison of histopathology, digital pathology and MRI-PDFF

THU-036 Cost-effectiveness of sequential non-invasive testing strategies to optimise hepatology referrals in MASLD: implications for primary care pathways

THU-381 Combining observation and patient data to predict malignancy progression in LI-RADS 3–4 observations

WED-105 Optimization of non-invasive screening algorithms for referral to liver elastography in the general population

WED-106 External validation of a standardized FLI without anthropometric data for the screening of significant liver fibrosis

WED-150 Refining the EASL two-step strategy for referral of patients with MASLD: a prospective multicenter primary care study

WED-151 Repeatability of mri biomarkers for monitoring patients with metabolic dysfunction-associated steatotic liver disease

WED-186-YI Combined serological testing to improve efficiency and sustainability in MASLD care

Impact of hepatic vessels on whole liver proton density fat fraction and R2* quantification

GDF15 is associated with hepatocellular senescence and correlates with mortality in patients with alcohol-associated hepatitis

Digital pathology and lipid droplet size as a key determinant of discrepancies between histology and MRI gradings in steatotic liver disease

Collaborators (28)

Vanesa Bernal-Monterde

Wenhao Li

Dorota Zarębska-Michaluk

Teresa Rubio-Tomás

Maria Pilar Ballester

Jorge Navarro-Pérez

Hajime Yamazaki

Jeffrey V. Lazarus

Kushala Abeysekera

Ramon Bataller

Philip Newsome

Radan Brůha

Robert Flisiak

Inmaculada Saurí-Ferrer

Susanne Rospleszcz

Susana Castan Cameo

Peter Jepsen

Rogério Ribeiro

Prasun K. Jalal

Rosa Martin-Mateos

Pau Sancho-Bru

Emmanuel Tsochatzis

Maxim S. Petrov

Claudio Luchini

Ornella Moreno-Mattar

Catarina Lindqvist

Ashwani Singal

Javier Crespo

Make your next move.